findmyKOL

Hussein Rayatzadeh, MD

Basic profile

Florida State University

ORCIDNone on fileNPI
RegionCanton, GA · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Hussein Rayatzadeh is a Cardiology physician affiliated with Florida State University. OpenAlex indexes 34 publications with 897 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
34publications

Distinct works indexed by OpenAlex.

897citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

460 Northside Cherokee Blvd Ste 150
Canton, GA 301158018

Telephone

470-639-6250

Provider last certified this registry record 5 Feb 2026.

View the NPPES registry record

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83%
    Statin24.1%
    Atorvastatin Calcium49%Rosuvastatin Calcium45%Pravastatin Sodium5%Lovastatin1%Simvastatin1%
    Part D<11 patients
    Beta blocker19.1%
    Metoprolol Succinate66%Carvedilol21%Metoprolol Tartrate10%Atenolol2%Nadolol1%
    Part D<11 patients

    + 18 more classes in this area

  • Blood & clotting

    8.8%
    Factor Xa inhibitor7.4%
    Eliquis90%Xarelto11%
    Part D<11 patients
    P2Y12 inhibitor1.2%
    Clopidogrel100%
    Part D26 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    8.2%
    SGLT2 inhibitor5%
    Jardiance79%Farxiga21%
    Part D60 patients
    Biguanide (metformin)1.5%
    Metformin Hcl100%
    Part D38 patients

    + 2 more classes in this area

Where care is delivered (Part B)11.5% facility · 88.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”